425 related articles for article (PubMed ID: 26231560)
1. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
[TBL] [Abstract][Full Text] [Related]
2. High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma.
Sui P; Hu P; Zhang T; Zhang X; Liu Q; Du J
Med Oncol; 2014 Feb; 31(2):809. PubMed ID: 24338377
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognosis of patients with esophageal carcinoma invading adjacent structures found during esophagectomy.
Kosugi S; Ichikawa H; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
J Surg Oncol; 2012 Jun; 105(8):767-72. PubMed ID: 22473575
[TBL] [Abstract][Full Text] [Related]
4. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
5. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
[TBL] [Abstract][Full Text] [Related]
7. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma.
Shim YM; Kim HK; Kim K
J Thorac Oncol; 2010 May; 5(5):707-12. PubMed ID: 20421764
[TBL] [Abstract][Full Text] [Related]
8. Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.
Hatogai K; Fujii S; Kojima T; Daiko H; Nomura S; Doi T; Kitano S; Ohtsu A; Takiguchi Y; Yoshino T; Ochiai A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2351-2361. PubMed ID: 28756492
[TBL] [Abstract][Full Text] [Related]
9. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
10. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
[TBL] [Abstract][Full Text] [Related]
11. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
[TBL] [Abstract][Full Text] [Related]
12. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
[TBL] [Abstract][Full Text] [Related]
13. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis.
Wang S; Wang Z; Yang Z; Liu Y; Liu X; Shang B; Jiang WP
Ann Surg Oncol; 2016 Jan; 23(1):265-72. PubMed ID: 26014154
[TBL] [Abstract][Full Text] [Related]
15. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy.
Hiyoshi Y; Morita M; Kawano H; Otsu H; Ando K; Ito S; Miyamoto Y; Sakamoto Y; Saeki H; Oki E; Ikeda T; Baba H; Maehara Y
Ann Surg Oncol; 2015 Jan; 22(1):240-6. PubMed ID: 25124469
[TBL] [Abstract][Full Text] [Related]
17. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy.
Hayami M; Watanabe M; Ishizuka N; Mine S; Imamura Y; Okamura A; Kurogochi T; Yamashita K
J Surg Oncol; 2018 May; 117(6):1251-1259. PubMed ID: 29205358
[TBL] [Abstract][Full Text] [Related]
20. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
